Frontier Bio
PrivateLast Round
Crowdfunding
Mar 4, 2026
Total Funding Raised
$1.62M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Frontier Bio operates in Healthcare & Life Sciences and is based in Hayward, California. Its latest recorded funding round was a Crowdfunding round in March 2026.
Frontier Bio is a biotechnology company that develops lab-grown human tissues and vascular grafts to provide an alternative to animal testing and address the organ transplant shortage.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, 3D Printing, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Frontier Bio Comparables
Compare Frontier Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FluidForm Bio | 84% | |
| Vivodyne | 82% | |
| Hesperos Inc. | 78% |
For institutional investors. Book with your work email.
Frontier Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Mar 4, 2026 | ||||
| Seed | Aug 29, 2025 | ||||
| Accelerator | May 1, 2025 | ||||
| Grant | Aug 15, 2021 | ||||
| Seed | May 14, 2020 | ||||
Accelerator | May 2, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Frontier Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartX | Seed |
| Brinc | Accelerator |
| Boutique Venture Partners | Seed |
| Break Off Capital | Seed |
| America's Seed Fund | Grant |
| Alchemist Accelerator | Seed, Accelerator |
| Immortal Dragons | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
Won 'Best Paper' award at the 50th Annual VESS meeting.
- Apr 9, 2026
Received Best Paper Award at the VESS Annual Meeting.
For institutional investors. Book with your work email.
Frontier Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Frontier Bio's valuation, stock price, and market status.
Is Frontier Bio a public or private company?
Frontier Bio is a private company.
What is the current stock price of Frontier Bio?
Frontier Bio is a private company, so its shares have no public market price. Caplight tracks Frontier Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Frontier Bio worth (valuation)?
Valuation information for Frontier Bio is not publicly available.
Can I buy Frontier Bio stock?
Frontier Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Frontier Bio's last funding round?
Frontier Bio's most recent funding round was Crowdfunding on March 4, 2026.
Who are the main investors in Frontier Bio?
Key investors in Frontier Bio include Immortal Dragons, National Science Foundation.
Will Frontier Bio IPO soon?
No public IPO plans have been announced for Frontier Bio.
How can I track Frontier Bio secondary market activity?
Caplight tracks bids, offers, and trades in Frontier Bio's shares on secondary markets.